The dynamics of drug treatment in epilepsy: An observational study in an unselected population based cohort with newly diagnosed epilepsy followed up prospectively over 11-14 years

Journal of Neurology Neurosurgery and Psychiatry

Volumn 71, Issue 5, 2001, Pages 632-637

  Lhatoo, S D ^a   Sander, J W A S ^a   Shorvon, S D ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Epilepsy; Population based cohort; Treatment

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; GABAPENTIN; LAMOTRIGINE; PHENYTOIN; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE CONTROL; EPILEPSY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; REMISSION; SIDE EFFECT; TREATMENT OUTCOME; UNITED KINGDOM;

EID: 0034782023     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.71.5.632     Document Type: Article

References (19)

1. Sander JWAS, Shorvon SD. Epidemiology of the epilepsies. J Neurol Neurosurg Psychiatry 1996;61:443.
2. Hart YM, Shorvon SD. The nature of epilepsy in the general population. I. Characteristics of patients receiving medication for epilepsy. Epilepsy Res 1995;21:43-9.
3. Hart YM, Sander JWAS, Shorvon SD. National General Practice Study of Epilepsy and Epileptic seizures: Objectives and study methodology of the largest reported prospective cohort study of epilepsy. Neuroepidemiology 1989;8:221-227.
4. The Commission on classification and terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981;22:489-501.
5. Evidence Medicine Working Group. Evidence based medicine: a new approach to teaching the practice of medicine. JAMA 1992;268:2420-5.
6. Hart YM, Sander JW, Johnson AL, et al. National general practice study of epilepsy: recurrence after a first seizure. Lancet 1990;336:1271-4.
7. Cockerell OC, Johnson AL, Sander JW, et al. Remission of epilepsy: results from the National general practice study of epilepsy. Lancet 1995;346:140-4.
8. Cockerell OC, Johnson AL, Sander JW, et al. Prognosis of epilepsy: a review and further analysis of the first 9 years of the British national general practice study of epilepsy, a prospective population-based study. Epilepsia 1997;38:31-46.
9. Cockerell OC, Johnson AL, Sander JW, et al. Mortality from epilepsy: results from a prospective population-based study. Lancet 1994;344:918-21.
10. Shorvon SD. The temporal aspects of prognosis in epilepsy. J Neurol Neurosurg Psychiatry 1984;47:1157-65.
11. Hauser WA, Andersen VE, Loewenson RB, et al. Seizure recurrence after a first unprovoked seizure. N Engl J Med 1982;307:522-8.
12. Yahr MD, Sciarra D, Carter S. Evaluation of standard anticonvulsant therapy of 319 patients. JAMA 1952;150:663-7.
13. Shorvon SD, Chadwick D, Galbraith AW, et al. One drug for epilepsy. BMJ 1978;1:474-6.
14. Mattson RH. Drug treatment of uncontrolled seizures. Epilepsy Res 1992;(suppl 5):29-35.
15. Sillanpaa M. Carbamazepine and oxcarbazepine. In: Shorvon SD, Dreifuss F, Fish DR, et al, eds. The treatment of epilepsy. Oxford: Blackwell, 1996:403-13.
16. Bruni J. Valproate. In: Shorvon SD, Dreifuss F, Fish DR, et al, eds. The treatment of epilepsy. Oxford: Blackwell, 1996:482-90.
17. Mattson RH, Cramer JA, Collins JF. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalised tonic-clonic seizures in adults. The Department of Veteran Affairs Epilepsy Cooperative Study No 264 Group. N Engl J Med 1992;327:765-71.
18. Snead OC, Hosey LC. Exacerbation of seizures in children by carbamazepine. N Engl JMed 1985;313:916-21.
19. Heller A, Chesterman P, Elwes RD, et al. Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparitive monotherapy trial. J Neurol Neurosurg Psychiatry 1995;58:44-50.